HRT raises risk of rare, treatable breast cancer

A study of women using hormone replacement therapy after menopause found that the treatment does not increase the risk of highly malignant breast cancer but does raise the risk of some uncommonforms of the disease that are slow growing and highly treatable. Some previous studies have shown that women who take oestrogen after menopause are more likely to …